Breast cancer with low to intermediate her2 expression Clinical Trials

Delta Trials catalogs 2 clinical trials for Breast cancer with low to intermediate her2 expression in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 1 trial have reached completion. This research occurs across 171 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.